News

EL partners with Profound to improve brand visibility and accuracy across generative AI platforms as beauty discovery evolves.

Bath & Body Works (BBWI) shares jumped Wednesday as the company raised its full-year earnings outloo

Ulta Beauty's (ULTA) fiscal second-quarter same-store sales growth is expected to top market estimat

The beauty group's repricing rests on a profit plan it controls, while the low end of its new sales guidance is no faster than the year just ended.

The beauty products leader's profit growth plan is working.

Estee Lauder (EL) shares rallied Wednesday after the cosmetics maker bumped up its fiscal 2027 opera

EL beats fiscal fourth-quarter estimates as sales rise 6%, fueled by Skin Care and Fragrance growth and sharply higher operating income.

On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.

Estee Lauder Companies Inc (NYSE:EL, XETRA:ELAA) shares jumped more than 15% on Wednesday after the beauty group posted fourth-quarter results that beat Wall Street estimates and raised its profit margin outlook for fiscal 2027. The company reported revenue of $3.6 billion for its fiscal...

Shares of Estée Lauder advanced on Wednesday as the beauty and cosmetics giant’s better-than-expected quarterly earnings showed Wall Street its growth plan is well underway. The company announced adjusted earnings of 39 cents a share in the fiscal fourth quarter, up from 9 cents a year ago and above Wall Street’s expectation of 32 cents. Estée Lauder reported adjusted earnings of $2.51 a share for the full fiscal year, up from $1.51 last year.

Beauty products company Estée Lauder (NYSE:EL) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 6.4% year on year to $3.63 billion. Its non-GAAP profit of $0.39 per share was 23% above analysts’ consensus estimates.

The cosmetics company forecast fiscal 2027 adjusted EPS of $3.10 to $3.35, with the midpoint above analyst estimates

Estee Lauder (EL) delivered earnings and revenue surprises of +21.88% and +2.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Investing.com -- Estee Lauder shares jumped after the beauty company forecast full-year profit above Wall Street estimates, betting on sustained demand for premium fragrances and strong performance in key markets as its turnaround strategy continues to bear fruit.

Estée Lauder (NYSE:EL) shares moved sharply higher after the beauty group issued a fiscal 2027 profit forecast that came in above Wall Street expectations, supported by resilient demand for premium fragrances and improving performance across important markets. The company also delivered better-than-expected fourth-quarter results.

Estée Lauder Cos. posted quarterly results that beat estimates and ended a run of three straight declines in annual revenue, a sign the beauty conglomerate's turnaround efforts are gaining momentum.

ELF's faster portfolio growth, Rhode momentum and raised fiscal 2027 outlook strengthen its case, but premium valuation and core-brand softness raise execution risks.

ELF's 18.8% weekly surge is backed by Rhode growth, stronger guidance and global expansion, though core softness and a premium valuation raise execution stakes.

Estee Lauder (EL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

e.l.f. Beauty tops Q1 estimates as Rhode delivers $160 million in sales, international revenues jump 61%, and fiscal 2027 guidance is raised.

Top-ranked stocks EL, BCC, THC, SIMO and VLO are likely to beat on the bottom line in their upcoming releases.

Estee Lauder (EL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

These two beaten-down consumer giants could reward investors willing to look past today's challenges and think 10 years ahead.

HELE tops fiscal first-quarter estimates, lifts fiscal 2027 sales outlook and sees net sales rise on growth across Home & Outdoor and Beauty & Wellness.

(Bloomberg) -- The year was tipped to be a potential blockbuster in deals and the first half delivered, setting a pace that is likely to continue in the closing months of 2026.Most Read from BloombergSpaceX IPO Left Mirae With No Shares on MisunderstandingSupreme Court Backs Birthright Citizenship in Blow to TrumpTrump Reports at Least $1.4 Billion in 2025 Crypto EarningsWhatsApp Opens Username Reservations to 3 Billion UsersYen Hits Four-Decade Low in Historic Slide That’s Rattled JapanFrom wel

EL, HELE, NUS, KVUE and IPAR stand out as beauty and cosmetics stocks backed by growth strategies for 2H 2026.

EL, ARKO, ATEYY, GDOT and BEN have been added to the Zacks Rank #1 (Strong Buy) List on June 23rd, 2026.

BEN, EL and ARKO made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 23rd, 2026.

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.

CAT, V, SBUX, KO and EL are five non-tech wide-moat stocks positioned for stable returns in 2H 2026.